Sinotherapeutics Inc. (SHA:688247)

Sinotherapeutics Revenue

In the year 2025, Sinotherapeutics had annual revenue of 446.57M CNY, down -12.71%. Sinotherapeutics had revenue of 115.10M in the quarter ending December 31, 2025, a decrease of -22.75%.

• Revenue: 446.57M
• Revenue Growth: -12.71%
• P/S Ratio: 9.21
• Revenue / Employee: 1.43M
• Employees: 312
• Market Cap: 4.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	446.57M	-65.05M	-12.71%
Dec 31, 2024	511.62M	211.75M	70.61%
Dec 31, 2023	299.87M	52.31M	21.13%
Dec 31, 2022	247.56M	-67.91M	-21.53%
Dec 31, 2021	315.47M	-3.69M	-1.16%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error